Lygos is an industrial biotechnology company developing a commercial bioprocess for manufacturing bio-based malonic acid. It was founded in 2010 by Eric Steen, Jay Keasling, and Jeffrey Dietrich in Berkeley, California.
Lygos received support from the United States Department of Energy (DOE) for their work on microbial fermentation technology to produce malonic acid. The bioprocess will lower the environmental impact and cost of manufacturing the specialty chemical compared to petroleum-based production processes.
Lygos received $120k in seed funding from Y Combinator, FundersClub, Fifty Years, Brainchild Holdings, and 10xGroup.
The funding round led by IA Ventures and First Round Capital, along with Y Combinator Continuity Fund and OS Fund closed at $15.5 million dollars in July 2018.
Visolis, Lygos pick up support via DOE’s Small Business Vouchers Pilot Program, as DOE opens funding Round 2
Documentaries, videos and podcasts
- BiotechnologyBiolotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- BiochemistryStudy of chemical processes in living organisms
- Synthetic biologyInterdisciplinary branch of biology and engineering, applying multiple disciplines to build artificial biological systems for research, engineering, and medical applications.
- Y CombinatorY Combinator (also known as YC) is a US based seed accelerator, which was started in March 2005.